SP
Sridhar Pusapati Raju
About Sridhar Pusapati Raju
Data last updated:
Sridhar Pusapati Raju is a Director at B E Immuno Sciences Private Limited (since 1999), Managing Director at Seishin Advanced Material Technologies Private Limited (since 2002) and Director at Ninachi Tech Private Limited (since 2017), and holds 1 more current directorship. The companies operate in Pharma, Chemicals and Materials and Information Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹21 Lakh; the largest is B E Immuno Sciences Private Limited at ₹10.1 Lakh (FY 2025). Earlier, Sridhar Pusapati Raju was a Director at Trisai Infra Private Limited (1995–2023) and Additional Director at Be Vaccines Private Limited (from 2013) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 May 1999 | 1999 | ₹10.1 Lakh (FY 2025) | Active | |
| Managing Director | 15 Oct 2002 | 2002 | ₹9 Lakh (FY 2025) | Active | |
| Director | 30 May 2017 | 2017 | ₹1.9 Lakh (FY 2022) | Active | |
| Designated Partner | 28 Nov 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Mar 1995 | 1995 | Converted To Llp | ||
| Additional Director | 12 Apr 2013 | 2012 | Strike Off | ||
| Director | 09 Oct 2003 | 2002 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sridhar Pusapati Raju
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahima Datla | 00965039 | B E Immuno Sciences Private Limited | Director |
| Mantena Purnima | 00965007 | B E Immuno Sciences Private Limited | Additional Director |
| Ramachandraraju Venkata Appala Sri Datla | 00341664 | Seishin Advanced Material Technologies Private Limited | Whole-Time Director |
| Trishanya Raju Pusapati | 07826704 | Ninachi Tech Private Limited | Director |
| Venkatapathi Raju Pusapati | 08624546 | Kalpa Real Estate Investment Management Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sridhar Pusapati Raju
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sridhar Pusapati Raju
Sridhar Pusapati Raju currently holds 4 directorships: B E Immuno Sciences Private Limited (Director, since 24 May 1999, revenue ₹10.1 Lakh (FY 2025)); Seishin Advanced Material Technologies Private Limited (Managing Director, since 15 Oct 2002, revenue ₹9 Lakh (FY 2025)); Ninachi Tech Private Limited (Director, since 30 May 2017, revenue ₹1.9 Lakh (FY 2022)); Kalpa Real Estate Investment Management Llp (Designated Partner, since 28 Nov 2019).
Sridhar Pusapati Raju was first appointed on 29 Mar 1995 as Director at Trisai Infra Private Limited. The most recent appointment on record is 28 Nov 2019 at Kalpa Real Estate Investment Management Llp.
The 3 current companies of Sridhar Pusapati Raju that report revenue have a combined latest revenue of ₹21 Lakh: B E Immuno Sciences Private Limited ₹10.1 Lakh (FY 2025); Seishin Advanced Material Technologies Private Limited ₹9 Lakh (FY 2025); Ninachi Tech Private Limited ₹1.9 Lakh (FY 2022).
Sridhar Pusapati Raju held 3 earlier board appointments: Trisai Infra Private Limited (Director, 29 Mar 1995 to 04 Dec 2023); Be Vaccines Private Limited (Additional Director, from 12 Apr 2013); Quest Minerals Private Limited (Director, from 09 Oct 2003).
The current boards of Sridhar Pusapati Raju's companies include Mahima Datla (B E Immuno Sciences Private Limited), Mantena Purnima (B E Immuno Sciences Private Limited), Ramachandraraju Venkata Appala Sri Datla (Seishin Advanced Material Technologies Private Limited), Trishanya Raju Pusapati (Ninachi Tech Private Limited), Venkatapathi Raju Pusapati (Kalpa Real Estate Investment Management Llp).